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The intimate association of the heat-labile (L) and heat-stable  (S)  soluble 
antigens of vaccinia was shown by the work of Craigie and Wishart (1).  More- 
over, observations on the degraded forms of these antigens,  reported in the 
previous paper (2), further indicated the close relationship of these two anti- 
gens.  The fact that the L-antigen is readily denatured by a  number of pro- 
cedures which are ordinarily used for purification of immunologically active 
substances  has  delayed the  acquisition  of knowledge concerning its  nature. 
On  the other hand,  the heat-stable antigen has been studied in considerable 
detail  (3, 4)  and has been shown to be a  protein substance.  Although  the 
results of several experiments (4, 5) have been interpreted as indicating that 
L-antigen may be obtained free of the S-antigen, these experiments are also 
subject to a different interpretation (2).  The work reported here was under- 
taken in the hope of obtaining pure L-antigen in sufficient amounts to study 
its physical and immunochemical properties.  As will be shown, the L-antigen 
is  not found free from the  S-reacting substance  under  ordinary conditions. 
Indeed, the results indicate that the L- and  S-immunological activities reside 
in a single native protein molecule.  A method for isolating pure LS-antigen of 
vaccinia from virus-free filtrates of  infected rabbit skin will be given in this 
communication together with observations on the physical and immunological 
properties of the native substance and of some of its degraded forms. 
Materials and Methods 
Vaccine Dermal  Filtrate.--Dermal filtrate was  available  in large  quantities as a 
by-product obtained from the preparation of washed  elementary bodies of vaccinia 
which were used for other studies.  The technique of Craigie (6) was employed with- 
out significant modification.  Dermal pulp from each cutaneously infected rabbit was 
suspended  in 30 cc. of a  1:50 dilution of standard phosphate buffer solution pH 7.2 
and the solution which  remained after removal of tissue  particles and elementary 
bodies  by means of differential  centrifugation was  filtered  immediately through a 
Seitz pad.  Bacteriologically  sterile virus-free filtrates were stored at 3°C. until 800 
to 1200 cc. had been accumulated, usually a period of a month. 
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Antiserum.--L-antiserum used throughout this portion of the work was prepared 
from pooled sera obtained by bleeding vaccine virus immune rabbits which had been 
hyperimmunized with washed active elementary bodies of vaccinia; the serum was 
absorbed  free  of  S-antibody with  heated  crude  dermal  filtrate.  S-antisera  were 
obtained from rabbits which had been immunized with a  non-infectious solution of 
purified S-antlgen (4).  Precautions were taken to prevent these non-immune animals 
from becoming accidentally infected with vaccinia during the period of immunization. 
Our experience, like that of Parker, indicated that solutions of S-antigen prepared in 
this manner elicit a poor antibody response in rabbits and in order to obtain potent 
sera several courses of treatment were given.  For the final course of immunization, 
washed and graded collodion particles were added to the solution of S-antigen and the 
mixture was injected intravenously. 
Serological Methods.--The serological techniques employed in this work have been 
reviewed in a  previous paper  (2). 
Electrophoret~c Technique.--Electrophoretic  experiments were  carried out  in  the 
Tiselius apparatus with the schlieren-scanning optical system (7) the details of which 
have been discussed elsewhere.  The temperature of the thermostat containing the 
cell was regulated at I°C., but all the values of mobility given in this paper have been 
corrected to  0°C. 
EXPERIMI~.NTAL 
Observations  on Concentrated  Whole Dermal Filtrate.--The results obtained 
in studies in which the electrophoretie technique was applied to concentrated 
dermal filtrate, both before and after heating, are illustrated in the following 
experiments. 
Experiment/.--One liter of dermal filtrate was concentrated to a volume of 100 cc. 
by means of evaporation through a cellophane sausage casing placed in an air stream 
at  room  temperature  for  24  hours.  The  L-  and  S-titers  of  this  concentrate 
were 1 : 1000.  A portion of the material was dialyzed against 0.05 M lithium-veronal 
buffer solution at pH 7.9.1  Upon electrophoresis this dialyzed material was found 
to display four boundaries, all of which corresponded to negatively charged substances 
at this value of pH.  A reproduction of the electrophoretic pattern obtained is shown 
in Fig. 1.  The mobilities of the four components, which were designated I to IV, were 
6.7  ×  10 -5, 5.4  )<  10 -5, 4.4  ×  10 -s, and 3.4  ×  10 -s cm./sec, per volt/cm., respec- 
tively.  In Fig.  1, as in subsequent figures, the first peak on the right, E, does not 
correspond to any component, but is due to a gradient of buffer salts. 
Experiment 2.--A portion of the same material was heated at 70°C. for ~  hour in a 
closed vessel (a procedure which inactivates L  without destroying S) and an electro- 
1 This  solution  contained  diethylbarbituric acid,  its  lithium  salt,  and  lithium 
chloride, each at 0.025 M.  The chloride was used to build up the ionic strength, since 
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phoretic determination  was made under  conditions  identical  with  those  described 
above.  The  electrophoretic  pattern  obtained  in  this  experiment is  illustrated  in 
Fig.  2. 
It is immediately obvious from Figs. 1 and 2, that the results obtained in the 
two experiments were strikingly different.  As a result of heating, one compo- 
nent (III) had completely disappeared and another component (II) had been 
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increased in amount; on the other hand, components I  and IV were unaffected 
by heating under these conditions.  A quantitative estimation of the relative 
amounts of components II and III in these two preparations was obtained from 
the measurement of the areas in the electrophoretic patterns.  This indicated 
that the increase in component II which occurred on heating was approximately 
equal to the loss of component III. 
When the observations described above were first made we were not certain 
whether L- and S-activities were associated with one or with two substances. 168  LS-ANTIGEN  OF VACCINIA.  II 
Therefore, we were  inclined  to believe from these  data  that  component III 
corresponded to L-antigen and that component II corresponded to S-antigen; 
furthermore, that as a result of heating, L had been transformed to S.  Let it 
be said at once that this hypothesis was subsequently proved wrong.  Never- 
theless, we immediately attempted to isolate by electrophoretic separation the 
four components shown in Fig. 1, in order to identify the  substances  serologi- 
cally.  These results may be briefly summarized as follows: components I, the 
fastest, and IV, the slowest, were readily isolated and were found to be sero- 
logically inert.  Sharp electrophoretic separation of components II and III was 
not possible,  due  to  the  fact that  their respective mobilities were not  suffi- 
ciently different for such resolution.  Even when electrophoresis was carried 
out  in  solutions with pH values from 6.0  to 8.6,  such  fractions which  were 
obtained  invariably showed L- and  S-activity in  equal amounts.  Since  the 
above methods were inadequate  for the purpose, fractionation of the L- and 
S-antigens from crude dermal filtrate was attempted by other means. 
Fractionation  of Dermal  Filtrate  by  _Precipitation.--It  has  been  shown  by 
Craigie and Wishart (1)  that the L- and S-antigens can be concentrated from 
crude dermal filtrate by precipitating at pH 4.5 and redissolving the precipitate 
at pH 6.5.  This procedure enabled these workers to eliminate a  considerable 
amount of serologically inert nitrogenous material, present in the crude filtrate, 
without appreciably reducing the titer of the antigens in the final preparation. 
Parker and Rivers  (3),  in their experiments dealing  with  the purification  of 
S-antigen from heated dermal filtrate, had also observed that the heat-stable 
active substance  has similar solubility  characteristics.  Procedures based on 
these observations were employed in the fractionation of concentrated dermal 
filtrate and  the fractions thus  obtained were studied  electrophoretically and 
serologically.  The  following  experiment  illustrates  the  methods  employed 
and the results obtained. 
Experiment 3.--1150 cc. of vaccine dermal filtrate, collected over a period of 5 weeks, 
were concentrated by evaporation from cellophane  bags to a volume of 110 cc.  The 
slight amount of insoluble  material present in the concentrate was removed by cen- 
trifugation and discarded.  The clear concentrate was again placed in a  cellophane 
sack and dialyzed overnight against 4 liters of unbuffered physiological saline solution 
at 3°C.  The sack and its contents were then suspended  in 450 cc. of 0.05 M acetate 
buffer solution  at pH 4.63, also at 3°C.  Precipitation began at once at the surface 
of the cellophane  membrane.  The sack was agitated from time to time and by the 
end of 3 hours no further increase  in the precipitate could be noted.  The material 
was then removed from the sack and the precipitate was separated by centrifugation 
in the cold.  The clear, straw-colored supernatant fluid, which had a pH of approxi- 
mately 4.6,  was set aside for further study;  this was designated fraction A.  The 
oyster-gray sediment, which occupied a volume of about 2 cc. in the centrifuge tube, 
was washed in the cold with 45 cc. of the same acetate buffer solution.  The resedi- T.  SHEDLOVSK¥  AND  J.  E.  SMADEL  169 
mented, washed material was then taken up in 50 cc. of 0.05 M cacodylate buffer solu- 
tion at pH 6.31 and dialyzed overnight against 450 cc. of the same  solution  at 3°C. 
Approximately half of the material dissolved under these  conditions.  The  material 
insoluble at pH 6.31 and the substance dissolved at this pH were  separated  by cen- 
trifugation.  The clear, pale straw-colored supernatant solution was labeled  fraction 
B and stored.  The sediment was washed with the cacodylate buffer solution and then 
suspended in  50  cc.  0.05  M veronal buffer solution of pH 8.56.  Following dialysis 
against a large volume of the same buffer solution an appreciable part, but not all, 
of the material dissolved.  The clear liquid was again separated from the precipitate 
by centrifugation  and designated fraction C.  The precipitate  which was insoluble 
at pH 8.56  dissolved partially  in 0.1  ~  borate  buffer solution pH  11.0 and almost 
completely in 0.05  ~  NaOH; since all the material in dermal filtrate  was originally 
soluble  in  neutral  solutions,  this  portion  probably  consisted  largely  of denatured 
products. 
The three fractions which had been saved for further study were: A, the material 
which remained soluble at pH 4.63; B, the material which was insoluble at pH 4.63 
but soluble at pH 6.31; and C, the material which was insoluble at pH 4.63 and 6.31, 
but soluble at pH 8.56.  Portions of fractions A and B were placed in cellophane sacks 
and dialyzed against 0.05 M lithium-veronal buffer solution at pH 7.91 for 1 or 2 days 
in  the cold, after which they were examined by electrophoresis;  similar  data  were 
obtained on fraction C in veronal buffer solution pH 8.56.  The serological properties 
of all three fractions were investigated. 
Fraction A was found to contain only two components; these had the same 
electrophoretic  mobilities  as  components  I  and  IV in  whole  dermal  filtrate. 
Fraction B  consisted of a single substance which was electrically homogeneous 
and which moved at a rate corresponding to that of component III.  Fraction 
C  contained a  trace of component III, but most of the material  appeared  to 
correspond  to component  II in whole filtrate.  The electrophoretic  patterns 
obtained with fractions A, B, and C are shown in Figs. 3, 4, and 5, respectively. 
The results  of serological studies  on the original material  and on fractions 
A, B, and C are summarized in Table I.  Briefly it may be stated that fraction 
B, consisting of the electrically homogeneous component III, contained prac- 
tically all of the L- and S-reacting material present in the original concentrated 
dermal filtrate.  It gave a  precipitate  when diluted  1:1600 and incubated in 
the presence of an optimum amount of L- or of S-antibody.  The small amount 
of L- and S-precipitinogen activity found in the C  fraction was  completely lost 
after refractionation; furthermore,  all of the serologically active material  was 
now recovered in the solution corresponding to the original B  fraction.  The 
A fraction was serologically inert. ~ 
This portion of the work may be summarized as follows.  Components I and 
2 In several early experiments  in  which dialysis of crude filtrate  against pH 4.6 
buffer solution was inadequate appreciable amounts of components II and III were 
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IV found  in  vaccine dermal  filtrate  may be  separated  quantitatively  from 
components II and III by precipitation of the latter at pH 4.6.  Furthermore, 
component III can be isolated from this precipitate in uncontaminated form 
by extracting this precipitate at pH 6.3.  Such a  solution of component III 
contains practically all of the L- and S-reactive substance present in the original 
filtrate. 
Observations  Indicating that a Single Substance in Its Native State Contains 
Both L- and S-Activity.--In  our laboratory, precipitation  titrations  with the 
TABLE  I 
Serological Activity of Fractions Derived  from Vaccine Dermal Filtrate 
Dilution of test solution 
Test solution 
1:25 
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dermal  fil- 
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Fraction B 
Fraction C 
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S 
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L-antiserum 1601 was used in a dilution of 1:2 throughout.  S-antiserum  493 was used 
in a dilution of 1:8.  0.01 ~ lithlum-veronal buffer solution, pH 8.6, containing 0.9 per cent 
of NaC1 served as diluent.  Test mixtures were incubated at 50°C. overnight. 
See text for preparation of test materials. 
soluble antigens of vaccinia are ordinarily carried out by incubating the antigen- 
antibody mixtures at 50°C. for 18 hours in closed tubes.  Such an incubation 
period is sufficient to degrade  the heat-labile antigen, L, to a state where it no 
longer  precipitates  with  its  antibody.  Consequently,  at  this  stage  in  the 
experiments it was necessary to consider the possibility that the material desig- 
nated as component III was a substance which possessed only L-activity in its 
native form.  According to such an hypothesis, this native material could be 
degraded by heating to a  substance with the electrical mobility of component 
II and with S-activity. 
In order to test this hypothesis  a solution containing  component  III was diluted 
serially in the usual manner,  and portions of each dilution  were placed in tubes with T.  SHEDLOVSKY  ANDS.  E.  SM.A.DEL  171 
optimal amounts of L- or of S-antibody.  Four sets of duplicate titrations were thus 
made and each set was incubated for 18 hours at a  different temperature,  namely, 
at 3  °, 20  °, 37 °, and 50°C. 
In each set of titrations the precipitin endpoint in the presence of S-antibody was 
identical with that obtained in the presence of L-antibody.  Flocculation was slower 
at the lower temperatures, and with incubation at 3°C. periods of 48 to 72 hours were 
necessary  in  order  to  develop  maximum  precipitation;  end-points  thus  obtained 
equalled those observed after 18 hours at 50°C. 
The presence of an S-reactive substance in solutions of component III which 
were incubated at temperatures  that do not change the precipitability  of the 
heat-labile  substance,  clearly  shows  that  component  III in  its  native  state 
possesses both L- and S-reacting portions; therefore, S cannot be a degradation 
product of L-antigen.  Observations reported in succeeding sections will clarify 
the relationship between component II and heated component III. 
Evidence based on absorption experiments in which solutions of component 
III were used  with L- and  with  S-antisera  indicates  that  the  two antigenic 
parts of component III cannot be separated by this method.  The following 
protocol illustrates  the  results  obtained  with  one  of several  preparations  of 
antigen absorbed with antisera. 
Experiment 4.---40 cc. of an electrophoreticaUy homogeneous solution of component 
III were obtained from 800 cc. of vaccine dermal filtrate by the method described in 
the protocol of Experiment 3.  The solution had a titer of 1:2048 with L- and with 
S-antibody.  A 0.7 cc. volume of S-antiserum 493 was mixed with 0.1 cc. of the solu- 
tion of antigen in one instance, and in another with 0.05 cc. of antigen and 0.05 cc. of 
saline.  Each antigen-antibody mixture was diluted with an equal volume of saline 
solution, and incubated at 37°C. for 4 hours, and  then at room temperature  for a 
similar period of time.  The voluminous precipitate which formed was removed by 
eentrifugation.  Similar absorptions were carried out with 0.8 cc. volumes of L-anti- 
serum 1601 and varying amounts (0.01 to 0.10 cc.) of solution of antigen, sufficient 
saline solution being added to each mixture to bring the final volume to 1.6 cc.  These 
were tested for residual antigen and for residual antibody.  The results of these tests 
which are summarized in Table II show that absorption with either L- or S-antibody 
removes both L- and S-antigenic substances completely or reduces both to the same 
degree. 
It is  apparent  from these  observations  that  the  electrically homogeneous  3 
component III, which was  obtained  from the  dermal filtrate,  contains  both 
L- and S-activity and that the two serologically distinct parts are inseparable in 
the native substance.  Ultracentrifugal and chemical studies on this material, 
which will be reported in another paper, showed it to be a  homogeneous protein 
3 Studies on the material at values of pH between 6.2 and 8.6 consistently revealed 
but one electrophoretic component.  These measurements are discussed in detail in a 
subsequent paper. 172  LS-ANTIGEN  OF VACCINIA.  II 
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with a molecular weight near that of serum globulins.  On the basis of electro- 
phoresis and ultracentrifugal evidence, therefore, we conclude that component 
III is a single molecular substance containing both L- and S-activity.  Hence- 
forth we shall designate  it as LS-antigen.  This LS-antigen  is probably the 
substance that Craigie and Wishart (1) prepared from the same type of source 
material and called "LS fraction."  Our method of isolation of the antigen is 
similar  to  theirs  and  the  serological  data  obtained  following  incubation  at 
various temperatures and by absorption with L- and  S-antibody agree with 
their findings.  The present experiments supplement the observations of these 
authors in that they were done with solutions of antigen which were proved to 
be pure by a  number of different criteria and hence these experiments carry 
additional weight in theoretical discussions of the nature of LS-antigen. 
Effect of Heat on LS-Antigen.--Destruction  of the precipitability of the labile 
soluble substance of vaccinia by heating has been well established (1, 5).  The 
combination between heated L- antigen and L-antibody without subsequent 
flocculation has been discussed  in  the preceding paper (2).  Since  pure  LS- 
antigen was now available it seemed desirable to study the effect of heat on its 
physical and serological characteristics. 
Experimen~ 5.--The observations described  in the following experiment are typical 
of those noted in the study of. several different  preparations of LS-antigen.  A portion 
of the solution  of LS-antigen  from Experiment 4 was heated  for ~  hour in a water 
bath at 70°C. in a  closed tube.  The solution which had been clear now showed a faint 
opacity.  After removing the trace of insoluble material by high speed centrifugation 
(12,000  R.I~.M.) the  solution  was  redialyzed against  0.05 M lithium-veronal  buffer 
solution at pH 7.91 and was examined by electrophoresis. 
The electrophoretic mobility of this lot of unheated LS-antigen under these condi- 
tions  was 4.0  ×  10 -s cm./sec, per volt/cm.  After heating this  solution, a  single 
electrically homogeneous  component was still present, but it now moved at a rate of 
5.9  X 10 -5 cm./sec, per volt/cm.  This preparation of heated LS was inhomogeneous 
when examined in the analytical centrifuge, as will be shown ill another paper in this 
series.  The precipitin titer of the solution  of unheated LS was 1:2048 with both L- 
and  S-antibody; the  heated LS still  titered  1:2048  with  S-antibody but  failed to 
precipitate  over  the  range  of  dilutions  from  1:8  to  1:4096  in  the  presence  of 
L-antibody. 
This experiment throws considerable light on the early observations which 
misled us into believing that components II and IlI represented S- and L-anti- 
gens respectively.  Heating destroyed the precipitability of the L-part of the 
LS-antigen and increased  the  mobility of the  degraded  molecule to a  value 
almost  identical  with  that  of  component  II in  crude  dermal  filtrate.  The 
augmentation of component II concurrent with the disappearance of compo- 
nent III in heated crude filtrate thus appears to have been a coincidence. 174  LS-ANTIGEN OF  VACCINIA.  II 
The Occasional Occurrence of Partially Degraded LS-Antigen in Crude Dermal 
Filtrate.--Although  pure  LS-antigen  had  been  previously obtained  in  four 
successive experiments by means of the fractionation technique which has been 
described,  it  was  found  in  one  experiment  that  the  fraction  which  usually 
contained  only LS-antigen was  contaminated  with  a  component  having  the 
mobility of either component II or of heated LS-antigen. 
Experiment 6.--850 cc. of dermal filtrate were concentrated and fractionated in the 
manner described in Experiment 3.  Fraction B  was examined by electrophoresis in 
0.05  M lithium-veronal buffer pH  7.89  and found to  contain two components; one 
component corresponding to LS-antigen was present in an appreciable amount, and 
the other, corresponding to either heated LS-antigen or component II, was estimated 
to be present in about ~  the concentration of LS-antigen.  Although the titer of the 
solution was 1:1600 with L-antibody and 1:3200 with S-antibody this was considered 
inconsequential at the time.  Accordingly, the solution was refractionated to remove 
the contaminating material.  In short, the material was precipitated three times at 
pH 4.6 and each time the precipitate redissolved almost completely at pH 6.6.  The 
final preparation gave essentially the  same electrophoretic pattern  and  serological 
titers as did the original fraction B. 
Refractionation of the solution which might have been expected to eliminate 
the contaminating material if it were component II failed to accomplish this. 
Furthermore,  since  the  contaminant  had  solubility characteristics similar to 
those of LS-antigen it appeared likely that it was a  degraded form of LS-anti- 
gen.  Therefore, at this point, it seemed desirable to know whether the tech- 
nique  of  fractionation,  as  regularly  employed,  was  adequate  to  separate 
heat-degraded LS-antigen from native LS-antigen. 
Experiment 6 (Continued).--14 cc. of the three times fractionated solution B from 
Experiment 6 were still available.  The solution had an S-titer of 1 : 1600 and L-titer 
of 1:800.  One half of the material was heated at 70°C.  for ~  hour.  This portion 
then failed to react with L-antibody but still retained its S-titer of 1 : 1600.  The two 
solutions were recombined; the precipitin titers were then  1:400 for L-antigen and 
1:1600 for S-antigen, as might have been expected. 
After dialysis, the mixture was again studied electrophoretieally; the pattern re- 
vealed the presence of two components with mobilities corresponding to LS-antigen 
and heated LS-antigen, which were present in concentrations closely corresponding to 
their respective titers.  The material was then subjected to the solubility  fractionation 
process and  was  again  examined  electrophoretically.  No  change  in  the  resulting 
pattern was noted.  The serological titers remained the same. 
Essentially similar electrophoretic and  serological observations were made on  a 
mixture containing equal amounts of solutions of unheated and heated LS-antigen 
from Experiment 3.  In this case, however, the two electrical components were about 
equal quantitatively, and  the  solution had  titers of  1:800  to  1:1600  with L- and 
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The results obtained in Experiment 6 indicate that heat-degraded LS-antigen 
has essentially the same solubility characteristic as native LS-antigen and hence 
cannot be separated from it by the procedures employed.  This is of importance 
for it indicates that, in general, dermal filtrate contains no partially degraded 
LS-substance,  i.e.,  one  possessing  S-activity  but  not  L-activity.  In  other 
words, all of the L- and S-activity in fresh dermal filtrate is carried by com- 
ponent III.  In the single experiment in which pure LS-antigen was not isolated 
by the process of fractionation it appears that the contaminant was a degraded 
form of antigen similar to heated LS-antigen.  The reason for the appearance 
of this contaminant in a single pool of dermal filtrate is not at hand.  It may 
be pointed  out,  however,  that,  unlike  the  usual  preparations,  in  this  case, 
several of the lots of the angle supernatant fluid from the suspension of crude 
pulp had not been filtered immediately, but were allowed to stand at ice box 
temperature for several days before being passed through a  Seitz pad.  The 
centrifuged but unfiltered fluid is slightly opalescent and contains some virus, 
tissue debris and bacteria, and the presence of one or more of these might well 
have contributed to partial denaturation of LS-antigen by enzymatic digestion 
or  otherwise. 
Inhibition of L- and S-Antibodies by Degraded Forms of LS-Antigen.--The 
interpretation of the experiments described in the previous paper (those dealing 
with  inhibition  of  anti-soluble-substance  antibodies  of  vaccinia  by  various 
preparations of materials from vaccine dermal filtrate) was difficult, due to the 
lack of critical evidence showing that the degradation products of a single sub- 
stance were capable of inhibiting the two antibodies.  Accordingly, solutions 
of pure LS-antigen were treated with heat alone, and also with heat and dilute 
alkali, and the specific inhibitory properties of the resulting preparations were 
studied  (Experiments 7 and 8). 
Experiment 7.--A portion of solution obtained from Experiment 3 was heated at 
70°C. for ~  hour.  The resulting solution  still precipitated in a dilution of 1:1600 
with optimal amounts of S-antibody but failed  to flocculate  when dilutions of 1:25 
to 1 : 3200 of the solution were mixed with optimal amounts of L-antibody.  Inhibition 
tests were made in the following manner.  Varying amounts of two different L-anti- 
sera were treated with varying amounts of heated LS-antigen solution.  Sufficient 
saline  solution was added to the test mixtures to make the final dilutions  of serum 
comparable.  The mixtures were incubated at 50°C. for ~  hour and then at 37°C. for 
an  additional  ~  hour.  The solutions  remained clear and centrifugation failed to 
sediment an appreciable amount of material.  The test sera, together with controls, 
prepared by properly diluting antisera with saline and incubating for a similar period, 
were then set up in constant amounts with serial twofold dilutions of unheated crude 
dermal filtrate.  Illustrative data obtained are summarized in Table Ill. 
It is evident from the results summarized in Table III that a  solution  of 
LS-antigen, shown to be pure by electrophoresis and ultracentrifugation, when 176  LS-ANTIGEN OF VACCINIA.  II 
degraded by heat to the stage where it fails to give a precipitin reaction with 
L-antibody, is still capable of combining with L-antibody as demonstrated by 
the inhibition technique.  An additional point of interest may be mentioned 
regarding the serological behavior of LS-antigen degraded by heat.  Mixtures 
of serial dilutions of such antigen and optimal amounts of L-antibody, which 
give no precipitate after incubation, were subsequently treated with optimal 
amounts of S-antibody and incubated in  the usual manner.  The precipitin 
titers  in  these  instances  were  approximately the  same as  those  obtained  in 
control  titrations  in  which no L-antibody was employed.  Apparently,  the 
presence of L-antibody, which was presumably combined with the degraded 
TABLE III 
Inhibition of L- and S-Antibody by Degraded Forms of 1.S-Antigen 
Inhibiting solution 
None 
LS heated 
LS heated with 
alkali 
Ratio of inhi- 
biting solution 
to antiserum 
1:1 
2:1 
1:1 
2:1 
1:1 
1/2:1 
I/4:1 
1/8:1 
Dilution of dermal filtrate 
Anti- 
seru/~3 
1:8  1:16  1:32  1:64 
L  +~++++ ++++  ++++  +++ 
S  ++++  ++++  ++++  +++ 
L  --  -- 
L  ++ 
L  4- 
S 
S 
S 
s  I  ++ 
++++  +++  ++ 
+++  +++  ++ 
+++  +  - 
+++++++++++ 
Saline + 
test 
1:128  mixture 
++ 
++ 
++ 
++ 
L-antiserum 1601 and S-antiserum 493 were used in the experiments summarized in this 
table. 
See legend of Table II and text for details of experiment. 
L-portion of the antigen, did not interfere with the union of the S-portion with 
its antibody and subsequent flocculation of the entire aggregate. 
Experiment 8.--A portion of the solution of heated LS-antigen used in Experiment 
7 was freed  of buffer  by dialysis  and  treated  with a  sufficient amount  of sodium 
hydroxide to bring the final concentration  to 0.1 M.  The material  was heated in a 
water bath at 50°C. in a closed vessel for 90 minutes  with frequent gentle agitation. 
After neutralization  to pH 7 the solution was titered with S-antibody.  The treatment 
failed to effect a complete loss of specific precipitability  of the solution, for the S-titer, 
although much diminished, was still 1:320.  Accordingly, the procedure was repeated 
except that 0.05 ~ concentration  of alkali was used.  Although the first treatment did 
not result in any change in the appearance  of the solution, this second treatment was 
accompanied by the production  of a small amount of insoluble material  which, inci- 
dentally,  was arranged  in  small, elongated  ribbon-like  fibers which  were white  in T.  SttEDLOVSKY  AND  J.  E.  SMADEL  177 
reflected light and colorless in transmitted light.  The insoluble material was removed 
and the solution tested in dilutions of 1:5 to 1:640 at pH 7 with optimal amounts of 
S-antibody.  No precipitation occurred. 
An inhibition experiment of the type described  in the previous section  was now 
performed.  L- and  S-antisera  were  treated  with  varying amounts of alkali-heat 
degraded antigen and subsequently tested for precipitable antibody.  The results 
of the experiment are summarized in Table III. 
It is apparent from the data presented in Table III that as little as 0.1 cc. 
of the  solution of LS-antigen which had been degraded by heat and  alkali 
(approximately 0.15 mg. of dried material) was sufficient to inhibit completely 
the S-antibody in the mixture.  Furthermore, even 1/~ of this amount of anti- 
gen was sufficient to inhibit the antiserum slightly.  On the other hand,  1.0 
cc. (1.5 mg.) was incapable of inhibiting the amount of L-antibody employed. 
Thus,  degradation  of LS-antigen  by  means  of  heat  and  alkali  completely 
destroys the serological activity of the L-portion of the molecule and changes the 
S-portion of the molecule to a form which no longer precipitates with S-antibody 
but is capable of inhibiting it.  It will be noted that the inhibitory action of the 
degraded  S-portion of  the  molecule on  S-antibody is  of a  greater  order  of 
magnitude than that of the degraded L-portion for its corresponding antibody. 
Electrophoretic studies on the solution of LS-antigen in Experiment 8 which 
had been degraded by heat and alkali showed that it contained one electrically 
homogeneous component with a mobility of 6.4 )<  10  -5 cm./sec, per volt/cm. 
at pH 7.9 and ionic strength 0.05.  The mobility of this substance is close to 
that of component I  in dermal filtrate.  The two are not identical, however, 
for the latter failed to inhibit S-antibody.  Furthermore, the two substances 
have different solubilities; the S-inhibitor is precipitated at pH 4.5 and fails 
to dissolve appreciably at pH 6.3, but it can be brought into solution between 
pH  8  and  9,  and  will  then  remain  in  solution  when  the  pH  is  lowered 
to nearly  7.0. 
DISCUSSION 
The experiments presented in this paper indicate that all of the serological 
activity associated  with  the  heat-stable  and  heat-labile  soluble  antigens  of 
vaccinia are present in a single protein molecule.  This differs somewhat from 
the concept of Craigie and Wishart  (5), who considered the two antigens to 
occur, ordinarily, in the form of a complex which could be dissociated into two 
separate antigens under certain circumstances. 
It is possible to state with assurance that various levels of degradation of LS- 
antigen can be accomplished, leaving either the L- or S-part of the molecule in a 
stage  where  it  can  still  combine with  the  corresponding  antibody  without 
precipitation.  The observations on inhibition of L- and S-antibody reported 
in the previous paper were not sufficiently conclusive to enable us to decide as 
to  the  nature and origin of the inhibiting substances.  On  the basis  of the 178  LS-ANTIGEN  0F VACCINIA.  II, 
present studies it is clear that they arise directly from the LS-antigen through 
partial degradation of the molecule. 
Here it has been shown that the L-portion of  the LS-molecule can be de- 
graded by heat without serological alteration of the S-portion.  In a  subse- 
quent paper in this series, it will be demonstrated that by means of enzymatic 
digestion the S-portion of the molecule can be degraded without altering the 
serological activity of the L-portion.  On the basis of  this latter observation 
it is possible to explain directly (2) the results occasionally obtained by other 
workers (4, 5), which had been interpreted (5) to indicate a dissociation of their 
LS-complex antigen into two separate components. 
SI/Ar~ARY 
Virus-free  filtrate,  obtained  from  suspensions  of  vaccine  virus-infected 
dermal pulp  of rabbits  and rich in  the soluble substances of vaccinia,  was 
shown  to  contain four distinct  components  in  electrophoresis  experiments. 
Electrophoretic and serological observations served as a guide in developing a 
method for  separating  these  components  from one  another.  This  method 
depended upon changes in the solubilities of the components with alterations 
of pH. 
Three of the four components appeared to be serologically inert when tested 
with anti-vaccinia sera.  All of the L- and S-activity was found to be asso- 
ciated with a single component which was electrically homogeneous at several 
values of pH and which was homogeneous in the ultracentrifuge. 
This single substance, designated as LS-antigen, precipitates in equal titers 
with optimal amounts of L- and of S-antibody and is completely removed from 
solution by absorption with either antibody. 
The LS-antigen of vaccinia appears to be a protein molecule with two anti- 
genically distinct parts, L  and S.  Heating modifies the L-portion in such a 
manner that the substance no longer precipitates with L-antibody; this de- 
graded antigen still combines with L-antibody, as is shown by inhibition tests, 
and still precipitates with S-antibody.  Similarly, treatment with heat and 
dilute alkali modifies the S-portion of LS-antigen so that it combines but does 
not precipitate with S-antibody; and at the same time all recognizable immuno- 
logical properties of the L-portion are destroyed. 
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